Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
1 clinical trials · Condition
◉ Watch Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
| Record | Firm | Date |
|---|---|---|
| Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer (NCT01225887) | Gynecologic Oncology Group | 2011-10-01 |
Track Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.